News Conference News AHA 2019 Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT Yael L. Maxwell November 17, 2019
News Conference News AHA 2019 ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD Todd Neale November 16, 2019
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Daily News Women Face Greater Post-PCI Stroke Risk Than Men, Study Confirms Caitlin E. Cox November 15, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Daily News Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms Todd Neale November 07, 2019
News Daily News Nighttime Hypertension Drug Dosing May Reduce Risk of CVD L.A. McKeown October 23, 2019
News Daily News Anticoagulant Type May Influence Fracture Risk in A-fib Patients Todd Neale October 21, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Industry News Penumbra Announces First Patient Enrolled In Study Of Mechanical Power Aspiration For Thrombus Removal In Coronary Vessels October 10, 2019
News Conference News TCT 2019 TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients Todd Neale October 03, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
Presentation TCT 2019 Residual Leak and Ischemic Stroke After LAA Closure: Whether to Close and if So, How? Presenter: George Hanzel September 27, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News TCT 2019 TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off Shelley Wood September 26, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019